Colgate Palmolive
NYSE CL · New York, NY
Works in Immunology · Infectious disease · Metabolic & endocrine · Neurology · Psychiatry · Respiratory
Colgate Palmolive is a clinical trial sponsor based in New York, NY, listed as NYSE CL. It has 14 active clinical trials with 11,487 planned participants, across 6 therapeutic areas. Since 2021 it has completed 64 trials and stopped 1 early.
Trial track record · since 2021
Financials · NYSE CL
Pipeline · 14 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Colgate Palmolive
Colgate Palmolive is lead sponsor of 14 active clinical trials on ClinicalTrials.gov, with 11,487 planned participants, in Immunology, Infectious disease, Metabolic & endocrine, Neurology and other areas. Since 2021 it has completed 64 trials and stopped 1 early.
Colgate Palmolive is based in New York, NY and is listed as NYSE CL. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Colgate Palmolive; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
Approve Suite is not affiliated with Colgate Palmolive.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.